EP0065974A1 - Antischuppenmittel - Google Patents

Antischuppenmittel

Info

Publication number
EP0065974A1
EP0065974A1 EP19820900018 EP82900018A EP0065974A1 EP 0065974 A1 EP0065974 A1 EP 0065974A1 EP 19820900018 EP19820900018 EP 19820900018 EP 82900018 A EP82900018 A EP 82900018A EP 0065974 A1 EP0065974 A1 EP 0065974A1
Authority
EP
European Patent Office
Prior art keywords
hydrochloride
imidazolylmethyl
sulfide
chloro
dichlorobenzyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19820900018
Other languages
German (de)
English (en)
French (fr)
Inventor
Peter Strehlke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19803046391 external-priority patent/DE3046391A1/de
Priority claimed from DE19813104430 external-priority patent/DE3104430A1/de
Application filed by Schering AG filed Critical Schering AG
Publication of EP0065974A1 publication Critical patent/EP0065974A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/006Antidandruff preparations

Definitions

  • the present invention relates to agents with anti-dandruff action, which act as active ingredients (3,4-dichlorobenzyl) - [2- (1-imidazolylmethyl) phenyl] sulfide, hydrochloride and 4-chloro-2- (l-imidazolylmethyl) diphenyl sulfide, hydrochloride contain.
  • anti-dandruff agents such as zinc or magnesium pyridine thione or selenium disulfide
  • Their mechanism of action consists in normalizing the significantly increased cell division activity in the epidermis in dandruff [Plewig, Klig ⁇ an Areh. clin. exp. Derm. 256, 406 (1970)].
  • Effective anti-dandruff agents also have an anti-camthogenic effect, i.e. they lead to thinning of the epidermis.
  • a reduction in toxicity would also be important as a promotion that is constantly being placed on modern medicinal products.
  • the effectiveness against dandruff in the individual compositions must not deteriorate under the usual storage conditions of a bathroom.
  • the antidandruff agent should also be inert towards other constituents of the application agent. Other characteristics of the active ingredient, such as color and smell, must meet the requirements that are placed on a cosmetic product today.
  • the invention relates to an agent for inhibiting scaling of the scalp, characterized in that it has an effective dose (3,4-dichlorobenzyl) - [2- (1-imidazolylmethyl) phenyl] sulfide, hydrochloride or 4-chloro-2- ( Contains 1-imidasolylmethyl) diphenyl sulfide, hydrochloride.
  • the invention also relates to the use of (3,4-dichlorobenzyl) - [2- (1-imidazolylmethyl) phenyl] sulfide, hydrochloride or 4-chloro-2- (1-imidazolylmethyl) diphenyl sulfide, hydrochloride for prophylactic and therapeutic treatment of the scalp against dandruff.
  • (3,4-dichlorobenzyl) - [2- (1-imidazolylmethyl) phenyl] sulfide, hydrochloride and 4-chloro-2- (1-imidasolylmethyl) diphenyl sulfide, hydrochloride are formulated in a manner known per se by being mixed with 0.1-5% by weight in ethanol / water or isopropanol / water for hair lotions or in 1-5% by weight for Sharapoos (hairdressing gels or inlay agents) and customary auxiliaries and carriers.
  • hair treatment agents which contain fatty alcohol-folyalkylene oxide adducts in their preparations, preferably those of fatty alcohols of chain length with 10-20 carbon atoms with 5-40 mol ethylene oxide units.
  • Possible hair treatment agents with an anti-dandruff effect are: hair shampoo, hair tonic, hair fixative, hairdressing cream, hair conditioner, hair treatment, hair lotion etc.
  • the anti-dandruff active ingredients (3.4-dichlorobenzyl) - [2- (1-imidazolylmethyl) - phenyl] sulfide hydrochloride and 4-Chloro-2- (1-imidazolylmethyl) diphenyl sulfide, hydrochloride in shampoos, hair lotions, inlay agents and hairdressing gels.
  • the agents mentioned contain other carriers and components customary in hair treatment compositions in the usual proportions.
  • Surfactant components such as fatty alcohol sulfates and fatty alcohol ether sulfates are intended for this purpose.
  • Amphoteric surfactants can also be used for this (eg miranols). The best preparations can be achieved with the above-mentioned surfactant component fatty alcohol polyalkylene oxide adduct.
  • Other additives are emulsifiers (e.g. Na, K or alkanolamine salts of fatty acids), thickeners (e.g. NaCl, NH 4 Cl in combinations with alkyl ether sulfates), superfatting agents (e.g.
  • polyoxyethylated lanolin derivatives such as lecithin derivatives or alkylolamides
  • framework components such as paraffin, full-fat alcohols, Protein breakdown products, vitamin complexes, solubilizers such as vinyl pyrrolidone-vinyl acetate copolymeridates, plant extracts.
  • the active substances should be used in amounts between 0.001 and 0.1 g per patient and per day.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP19820900018 1980-12-05 1981-12-04 Antischuppenmittel Withdrawn EP0065974A1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE3046391 1980-12-05
DE19803046391 DE3046391A1 (de) 1980-12-05 1980-12-05 Antischuppenmittel
DE3104430 1981-02-04
DE19813104430 DE3104430A1 (de) 1981-02-04 1981-02-04 Antischuppenmittel

Publications (1)

Publication Number Publication Date
EP0065974A1 true EP0065974A1 (de) 1982-12-08

Family

ID=25789617

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19820900018 Withdrawn EP0065974A1 (de) 1980-12-05 1981-12-04 Antischuppenmittel

Country Status (3)

Country Link
EP (1) EP0065974A1 (is")
JP (1) JPS57502126A (is")
WO (1) WO1982001819A1 (is")

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013000572A1 (de) 2011-06-30 2013-01-03 2LUTION GmbH Mittel zur bekämpfung von parasiten an tieren

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS571781B2 (is") * 1973-01-18 1982-01-12
JPS5426197B2 (is") * 1973-06-25 1979-09-03
IE40911B1 (en) * 1974-04-11 1979-09-12 Schering Ag Imidazole derivatives and process for their manufacture
DE2430039C2 (de) * 1974-06-22 1983-11-10 Bayer Ag, 5090 Leverkusen Climbazol in kosmetischen Mitteln
GB2068228B (en) * 1980-01-24 1984-02-29 Janssen Pharmaceutica Nv Anti-microbial compositions for the topical treatment of acne vulgaris

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO8201819A1 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013000572A1 (de) 2011-06-30 2013-01-03 2LUTION GmbH Mittel zur bekämpfung von parasiten an tieren

Also Published As

Publication number Publication date
JPS57502126A (is") 1982-12-02
WO1982001819A1 (en) 1982-06-10

Similar Documents

Publication Publication Date Title
DE2430039C2 (de) Climbazol in kosmetischen Mitteln
DE69326292T2 (de) Retinsäuren und Tocopherol enthaltende Zusammensetzungen
DE69526103T2 (de) Dermatologische zusammensetzungen, welche benzylneroxid und ein mittel zur verminderung von hautreizungen enthalten
US4439418A (en) Topical preparations for the treatment of seborrhea and process for inhibiting sebum production
EP1238645A2 (de) Antischuppenmittel
WO1992012699A1 (de) Kosmetische oder pharmazeutische zubereitungen zur verbesserung der haarqualität und förderung des haarwachstums
DE3534564A1 (de) Naphthalinderivate, verfahren zu deren herstellung und diese verbindungen enthaltende pharmatzeutische und kosmetische mittel
DE3707245C2 (de) 2,3,4,4a-Tetrahydro-4a,10,10-trimethyl - 1H-3, 9b - methandibenzofuranderivate, Verfahren zur Herstellung dieser Verbindungen und pharmazeutische und kosmetische Mittel, die diese Verbindungen enthalten
DE60313791T2 (de) Zusammensetzung für die Haarbehandlung, die ein Styrolpyrazol enthält
DE69700033T2 (de) Verwendung eines 2-Aminoalkan-1,3-Diol zur Verlangsamung des Haarausfalls und/oder zum Auslösen und Stimulieren des Haarwachstums
DE69621243T2 (de) Verwendung von bradykininantagonisten zur induzierung oder stimulation des haarwachstums und/oder zur verlangsamung des haarausfalls
DE69802249T2 (de) Neue N-Aryl-2-hydroxy-alkylamide
DE3012767A1 (de) Kosmetische mittel
JP2005530766A (ja) 4−ヒドロキシ−5−メトキシ−4−[2−メチル−3−(3−メチル−2−ブテニル)−2−オキシラニル]−1−オキサスピロ[2,5]オクタン−6−オンを含有する脂漏症治療用医薬組成物
DE1617704B2 (de) Haarbehandlungsmittel
DE3851139T2 (de) Tonikhaarlotion.
DE3738405A1 (de) Sebosuppressive zubereitungen
JPS6293215A (ja) 養毛料
DE3784821T2 (de) Zusammensetzung zur anwendung an haaren.
EP0740930B1 (en) Blood flow improver and cosmetic
DE102004012009A1 (de) Antischuppenmittel
EP0065974A1 (de) Antischuppenmittel
DE68907755T2 (de) Mittel zur Verhinderung der Ergrauung der Haare und Repigmentierung ergrauter Haare.
DE3016999A1 (de) Mittel zur staerkung und revitalisierung bruechiger und angegriffener naegel
EP0079899B1 (de) Topische kosmetische zubereitungen, enthaltend heteroarylmercapto-alkansäure-derivate als antiseborrhoische zusätze

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19820701

AK Designated contracting states

Designated state(s): AT CH DE FR GB LU NL SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Withdrawal date: 19831202

RIN1 Information on inventor provided before grant (corrected)

Inventor name: STREHLKE, PETER